Table 3.

Univariate probabilities of transplant outcomes among allogeneic transplant recipients with AP, CP2, and BP

	AP (N=185)	CP2 (N=184)	BP (N=80)
Outcome	Prob (95% CI)	Prob (95% CI)	Prob (95% CI)
Acute GVHD @ 100 days, grades (2–4)	49 (42–56)	51 (44–58)	40 (30–51)
Chronic GVHD
@ 1 year	51 (44–58)	52 (45–59)	22 (14–32)
@ 3 years	54 (46–61)	54 (46–61)	22 (14–32)
TRM
@ 1 year	34 (28–41)	33 (26–40)	46 (35–58)
@ 3 years	37 (30–44)	39 (32–46)	54 (42–65)
Relapse
@ 1 year	24 (18–30)	29 (22–35)	34 (24–45)
@ 3 years	26 (20–33)	34 (27–41)	36 (26–48)
LFS
@ 1 year	42 (35–49)	38 (31–45)	20 (11–29)
@ 3 years	37 (30–44)	27 (20–34)	10 (4–17)
Overall survival
@ 1 year	55 (48–60)	50 (42–57)	29 (19–39)
@ 3 years	43 (35–50)	36 (29–43)	14 (8–23)

Abbreviations: TRM = treatment-related mortality; LFS = leukemia-free survival; Prob = probability; CI = confidence interval.